University of Minnesota spinout Vigilant Diagnostics has closed a seed round that featured an unnamed Chinese investor.
Vigilant Diagnostics, a US-based spinout from University of Minnesota working on detection technology for infectious diseases, has closed a seed round of undisclosed size, Twin Cities Business reported yesterday.
The round featured an undisclosed Chinese investor and came in addition to a $300,000 phase 1 commercialisation grant provided by the US National Institutes of Health (NIH) under the federal Small Business Innovation Research program.
Founded in 2014, Vigilant Diagnostics is working on technology dubbed Thermal Contrast Amplification, which the spinout…
